Vysis CLL FISH Probe Kit with the following components: Vysis LSI p53 SpectrumOrange/ATM, Spectru...

FDA Device Recall #Z-2576-2021 — Class II — August 4, 2021

Recall Summary

Recall Number Z-2576-2021
Classification Class II — Moderate risk
Date Initiated August 4, 2021
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Abbott Molecular, Inc.
Location Des Plaines, IL
Product Type Devices
Quantity 186 units

Product Description

Vysis CLL FISH Probe Kit with the following components: Vysis LSI p53 SpectrumOrange/ATM, SpectrumGreen and LSI D13S319, SpectrumOrange/ 13q34, SpectrumAqua/CEP 12 SpectrumGreen Probes

Reason for Recall

Potential for Vysis CLL FISH Probe Kits not detecting 13q deletions in known positive patient samples.

Distribution Pattern

Worldwide distribution - US Nationwide distribution in the states of AZ, CA, FL, GA, IL, IN, KY, MI, MN, MA, NC, NJ, NM, NY, OH, PA, TN, TX, UT, VA, VT, WA, WI and the countries of Australia, Belgium, Brazil, Canada, China, Costa Rica, Czech Republic, Estonia, Germany, Hong Kong, Israel, Italy, Kazakhstan, Netherlands, Philippines, Poland, Saudi Arabia, Slovenia, South Africa, South Korea, Spain, United Kingdom, Uruguay.

Lot / Code Information

UDI: (01)00884999042780(10)XXXXX(17)211015(240)04N02-021; US Distribution: Part Number 04N02-021, Lot Numbers 517086, 518656; International Distribution: List/Part Numbers (Lot Number): 04N02-021 (517086, 518656), 04N02-022 (517516, 519303), 05J83-001/Part 32-191025 (517068).

Other Recalls from Abbott Molecular, Inc.

Recall # Classification Product Date
Z-1749-2025 Class II Alinity m Resp-4-Plex AMP Kit, List Number 09N7... Apr 28, 2025
Z-1748-2025 Class II Alinity m Resp-4-Plex Amplification (AMP) Kit (... Apr 28, 2025
Z-1665-2025 Class II The Alinity m System is designed to automate th... Mar 20, 2025
Z-0233-2025 Class II Abbott Alinity m HPV AMP Kit, used with the Ali... Sep 12, 2024
Z-0234-2025 Class II Abbott Alinity m STI AMP Kit, used with the Ali... Sep 12, 2024

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.